A new study, conducted largely in mice, may help explain why a biomarker called mismatch repair deficiency doesn’t always predict which patients will respond to immune checkpoint inhibitors, a type of immunotherapy.
For people with lung cancer or medullary thyroid cancer that has changes in the RET gene, the targeted therapy drug selpercatinib (Retevmo) may delay cancer growth longer than other common treatments.
The Food and Drug Administration has changed its 2021 approval of pembrolizumab (Keytruda) when it is combined with trastuzumab (Herceptin) and chemotherapy to treat HER2-positive stomach or esophageal junction cancer. The agency also announced a new approval of pembrolizumab for HER2-negative forms of these cancers.
Depression is a treatable medical problem that can affect adults and children with cancer. This updated page describes symptoms of depression, risk factors, diagnosis, and treatment for adults and children with cancer.
